208 related articles for article (PubMed ID: 26903185)
1. Cutaneous and ocular manifestations of neurocutaneous syndromes.
Chernoff KA; Schaffer JV
Clin Dermatol; 2016; 34(2):183-204. PubMed ID: 26903185
[TBL] [Abstract][Full Text] [Related]
2. Ocular manifestations of the neurocutaneous syndromes.
Greenwald MJ; Weiss A
Pediatr Dermatol; 1984 Oct; 2(2):98-117. PubMed ID: 6440131
[TBL] [Abstract][Full Text] [Related]
3. Introduction to phacomatoses (neurocutaneous disorders) in childhood.
Ruggieri M; Polizzi A; Marceca GP; Catanzaro S; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2229-2268. PubMed ID: 32940773
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of neurocutaneous syndromes.
Roach ES
Semin Neurol; 1988; 8(1):83-96. PubMed ID: 3146120
[No Abstract] [Full Text] [Related]
5. Renal involvement in neurocutaneous syndromes.
Khan GA; Melman A; Bank N
J Am Soc Nephrol; 1995 Jan; 5(7):1411-7. PubMed ID: 7703378
[No Abstract] [Full Text] [Related]
6. Neurocutaneous disorders in children.
Küster W; Happle R
Curr Opin Pediatr; 1993 Aug; 5(4):436-40. PubMed ID: 8374670
[TBL] [Abstract][Full Text] [Related]
7. The phakomatoses: dermatologic clues to neurologic anomalies.
Nowak CB
Semin Pediatr Neurol; 2007 Sep; 14(3):140-9. PubMed ID: 17980311
[TBL] [Abstract][Full Text] [Related]
8. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
9. Neurocutaneous syndromes.
Owen LG; Hanno R
Cutis; 1978 Jun; 21(6):848-51. PubMed ID: 95921
[TBL] [Abstract][Full Text] [Related]
10. Neurocutaneous syndromes.
Roach ES
Pediatr Clin North Am; 1992 Aug; 39(4):591-620. PubMed ID: 1635798
[TBL] [Abstract][Full Text] [Related]
11. Phacomatoses in the pediatric age group.
Constantini S; Schuhmann MU
Childs Nerv Syst; 2020 Oct; 36(10):2227-2228. PubMed ID: 32661640
[TBL] [Abstract][Full Text] [Related]
12. Intra-cranial manifestations of the neurocutaneous syndromes.
Herron J; Darrah R; Quaghebeur G
Clin Radiol; 2000 Feb; 55(2):82-98. PubMed ID: 10657153
[TBL] [Abstract][Full Text] [Related]
13. [CNS manifestations of neurocutaneous syndromes].
Yilmaz U
Radiologe; 2018 Jul; 58(7):664-667. PubMed ID: 29947935
[TBL] [Abstract][Full Text] [Related]
14. [Phacomatosis and genetically determined tumors: the transition from childhood to adulthood].
de Ribaupierre S; Vernet O; Vinchon M; Rilliet B
Neurochirurgie; 2008 Oct; 54(5):642-53. PubMed ID: 18752812
[TBL] [Abstract][Full Text] [Related]
15. Genetic aspects of neurocutaneous disorders.
Jentarra G; Snyder SL; Narayanan V
Semin Pediatr Neurol; 2006 Mar; 13(1):43-7. PubMed ID: 16818175
[TBL] [Abstract][Full Text] [Related]
16. [Skin symptoms in neurological diseases].
Burg G; Burg D
Ther Umsch; 1995 Apr; 52(4):243-50. PubMed ID: 7754467
[TBL] [Abstract][Full Text] [Related]
17. Current concepts of neurocutaneous disorders.
Berg BO
Brain Dev; 1991; 13(1):9-20. PubMed ID: 1905882
[TBL] [Abstract][Full Text] [Related]
18. [The tip of the iceberg: cutaneous manifestations of paediatric diseases with neurological involvement].
Brasileiro A; Afonso P; Diamantino F; Paiva Lopes MJ
Acta Med Port; 2015; 28(1):92-8. PubMed ID: 25817485
[TBL] [Abstract][Full Text] [Related]
19. Neurocutaneous syndromes: behavioral features.
Zaroff CM; Isaacs K
Epilepsy Behav; 2005 Sep; 7(2):133-42. PubMed ID: 15996528
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging. Its role in the neuroradiologic evaluation of neurofibromatosis, tuberous sclerosis, and Sturge-Weber syndrome.
Truhan AP; Filipek PA
Arch Dermatol; 1993 Feb; 129(2):219-26. PubMed ID: 8434982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
